Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,237
Total Claims
$996K
Drug Cost
1,339
Beneficiaries
$744
Cost/Patient
Risk Score Breakdown 49/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+1926%
Opioid rate vs peers
50.2% vs 2.5% avg
-34%
Cost per patient vs peers
$744 vs $1,128 avg
+28%
Brand preference vs peers
10.8% vs 8.4% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Opioid Prescribing
50.2%
Opioid Rate
5,636
Opioid Claims
$667K
Opioid Cost
28.9%
Long-Acting Rate
This provider's opioid prescribing rate of 50.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,213 claims · $633K
Generic: 10,024 claims · $363K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 243 | $153K |
| Buprenorphine Hcl | 177 | $146K |
| Buprenorphine | 483 | $144K |
| Buprenorphine Hcl/Naloxone Hcl | 303 | $70K |
| Hydrocodone Bitartrate | 62 | $41K |
| Buprenorphine Hcl/Naloxone Hcl | 79 | $39K |
| Oxycodone Hcl/Acetaminophen | 1,598 | $39K |
| Oxycodone Hcl | 80 | $38K |
| Hydrocodone/Acetaminophen | 1,792 | $36K |
| Buprenorphine | 51 | $29K |
| Naloxegol Oxalate | 64 | $26K |
| Linaclotide | 44 | $25K |
| Gabapentin | 1,499 | $20K |
| Pregabalin | 649 | $18K |
| Diclofenac Sodium | 426 | $14K |
Prescribing Profile
41
Unique Drugs
49.0
Anomaly Score
Patient Profile
66
Avg Age
64%
Female
1.64
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About